港股異動 | 獲機構扎推唱好 周黑鴨(1458.HK)大漲8%創逾3個月新高
格隆匯6月3日丨周黑鴨(1458.HK)大幅拉昇漲8%,報10.88港元創逾3個月新高價,總市值達260億港元。周黑鴨管理層於6月2日舉辦了投資者簡報會,公司計劃每年將開設800-1000家門店,並有信心在2023年能達到4000至5000家線下門店。從長遠來看,社區門店、熱燉食品或配菜產品會成為另一個增長驅動力。高盛維持周黑鴨買入評級,目標價11.4港元;海通證券表示,人流量持續恢復+加盟門店快速擴張,看好公司全年銷售規模大幅提升;中金維持公司今明兩年盈利預測,預計2022年收入和利潤分別同增28%/50%;興業證券維持周黑鴨“增持”評級,目標價12.6港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.